Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

Roberto Buzzoni,1 Carlo Carnaghi,2 Jonathan Strosberg,3 Nicola Fazio,4 Simron Singh,5 Fabian Herbst,6 Antonia Ridolfi,7 Marianne E Pavel,8 Edward M Wolin,9 Juan W Valle,10 Do-Youn Oh,11 James C Yao,12 Rodney Pommier13 1IRCCS Foundation, National Institute of Tumors, Milan, Italy; 2Humanitas Clinica...

Full description

Bibliographic Details
Main Authors: Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, Pavel ME, Wolin EM, Valle JW, Oh DY, Yao JC, Pommier R
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:OncoTargets and Therapy
Subjects:
neuroendocrine tumors
progression-free survival
somatostatin analogues
chemotherapy
PRRT
Online Access:https://www.dovepress.com/impact-of-prior-therapies-on-everolimus-activity-an-exploratory-analys-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/impact-of-prior-therapies-on-everolimus-activity-an-exploratory-analys-peer-reviewed-article-OTT

Similar Items